Daniel C. Bartos
Agios Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Cardiac electrophysiology and arrhythmias, Ion channel regulation and function, Neuroscience and Neural Engineering, Cardiomyopathy and Myosin Studies, ECG Monitoring and Analysis
Most-Cited Works
- → Long QT Syndrome–Associated Mutations in Intrauterine Fetal Death(2013)173 cited
- → Ion Channels in the Heart(2015)172 cited
- → The cardiomyocyte molecular clock, regulation of Scn5a , and arrhythmia susceptibility(2013)142 cited
- → Potassium channels in the heart: structure, function and regulation(2016)110 cited
- → The Promise and Peril of Precision Medicine(2016)96 cited
- → The cardiomyocyte molecular clock regulates the circadian expression of Kcnh2 and contributes to ventricular repolarization(2015)80 cited
- → R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation(2010)72 cited
- → A KCNQ1 Mutation Causes a High Penetrance for Familial Atrial Fibrillation(2012)60 cited
- → Quantitative analysis of the Ca2+‐dependent regulation of delayed rectifier K+ current IKs in rabbit ventricular myocytes(2016)45 cited
- → Trafficking-deficient hERG K+ channels linked to long QT syndrome are regulated by a microtubule-dependent quality control compartment in the ER(2011)34 cited